Laura Agensky
Nessuna posizione attualmente
Profilo
Laura Agensky worked as Vice President-Clinical Operations at Transition Therapeutics, Inc. She obtained an undergraduate degree and an MBA from McGill University.
Precedenti posizioni note di Laura Agensky
| Società | Posizione | Fine |
|---|---|---|
| TRANSITION THERAPEUTICS INC | Direttore operativo | 21/06/2009 |
Formazione di Laura Agensky
| McGill University | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Aziende private | 1 |
|---|---|
Transition Therapeutics, Inc.
 Transition Therapeutics, Inc. Medical SpecialtiesHealth Technology Transition Therapeutics, Inc. develops novel therapeutics for disease indications. It operates through research and development of therapeutic agents segment. The firm's products include ELND005 for the treatment of alzheimer's disease, bipolar disorder and down syndrome. Its metabolic drug candidate is TT401 for treatment of type 2 diabetes and accompanying obesity. Transition Therapeutics was founded by Tony F. Cruz on July 6, 1998 and is headquartered in Toronto, Canada. | Health Technology |
- Borsa valori
- Insiders
- Laura Agensky
